{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:47:37Z","timestamp":1762444057397},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.gtc.2006.07.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:09:23Z","timestamp":1168441763000},"page":"675-712","source":"Crossref","is-referenced-by-count":41,"title":["Chemoprevention: Risk Reduction with Medical Therapy of Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Erick P.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2006.07.003_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000441-192508010-00006","article-title":"The sigmoidoscopic picture of chronic ulcerative colitis","volume":"170","author":"Crohn","year":"1925","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gtc.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.35.11.1590","article-title":"Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tgie.2004.09.004","article-title":"Endoscopic evaluation for cancer and dysplasia in patients with inflammatory bowel disease","volume":"6","author":"Chan","year":"2004","journal-title":"Techniques in Gastrointestinal Endoscopy"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0016-5085(92)90831-I","article-title":"Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia","volume":"103","author":"Woolrich","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5107(00)70405-6","article-title":"How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance","volume":"51","author":"Eaden","year":"2000","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0016-5085(94)90216-X","article-title":"Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis","volume":"107","author":"Connell","year":"1994","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gut.52.8.1127","article-title":"Ten year follow-up of ulcerative colitis patients with and without low grade dysplasia","volume":"52","author":"Lim","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"Eaden","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.gtc.2006.07.003_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000279.pub2","article-title":"Strategies for detecting colon cancer and\/or dysplasia in patients with inflammatory bowel disease","volume":"2","author":"Mpofu","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl 5","key":"10.1016\/j.gtc.2006.07.003_bib14","doi-asserted-by":"crossref","first-page":"V10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/gast.2003.50044","article-title":"Colorectal cancer screening and surveillance: clinical guidelines and rationale\u2014update based on new evidence","volume":"124","author":"Winawer","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2006.07.003_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.MIB.0000160811.76729.d5","article-title":"Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease","volume":"11","author":"Itzkowitz","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib18","first-page":"1520","article-title":"Chemoprophylaxis of carcinogenesis: a review","volume":"26","author":"Wattenberg","year":"1966","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib19","first-page":"1332","article-title":"Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)","volume":"35","author":"Sporn","year":"1976","journal-title":"Fed Proc"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/93.10.743","article-title":"Chemoprevention: what's in a name?","volume":"93","author":"Theisen","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.gtc.2006.07.003_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.gtc.2006.07.003_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.gtc.2006.07.003_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2006.07.003_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004079.pub2","article-title":"Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas","volume":"2","author":"Asano","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.gtc.2006.07.003_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib26","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","article-title":"Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis","volume":"107","author":"Brentnall","year":"1994","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib28","first-page":"2035","article-title":"Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms","volume":"55","author":"Tarmin","year":"1995","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.gtc.2006.07.003_bib29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.29.2.206","article-title":"Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres","volume":"29","author":"Gyde","year":"1988","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00054725-200311000-00002","article-title":"Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis","volume":"9","author":"Mathy","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"issue":"4 Suppl. 2","key":"10.1016\/j.gtc.2006.07.003_bib33","first-page":"A-2","article-title":"Increased inflammatory activity is an independent risk factor for dysplasia and colorectal cancer in ulcerative colitis: a case-control analysis with blinded prospective pathology review","volume":"130","author":"Rubin","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2036.2006.02846.x","article-title":"Systematic review: the use of mesalazine in inflammatory bowel disease","volume":"23","author":"Bergman","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1568009043481632","article-title":"NSAIDs and chemoprevention","volume":"4","author":"Rao","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"issue":"26","key":"10.1016\/j.gtc.2006.07.003_bib38","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","article-title":"Chemoprevention of colorectal cancer","volume":"342","author":"Janne","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/003655202753416759","article-title":"Aminosalicylates: potential antineoplastic actions in colon cancer prevention","volume":"37","author":"Allgayer","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2036.18.s2.1.x","article-title":"Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease","volume":"18","author":"Allgayer","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"37","key":"10.1016\/j.gtc.2006.07.003_bib41","doi-asserted-by":"crossref","first-page":"26448","DOI":"10.1074\/jbc.274.37.26448","article-title":"Inhibition of interleukin-1-stimulated NF-kappaB RelA\/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity","volume":"274","author":"Egan","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gtc.2006.07.003_bib42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib43","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta","volume":"119","author":"Weber","year":"2000","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gtc.2006.07.003_bib44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1046\/j.1365-2036.1999.00652.x","article-title":"Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?","volume":"13","author":"Bus","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib45","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1158\/0008-5472.CAN-04-3824","article-title":"Mesalazine improves replication fidelity in cultured colorectal cells","volume":"65","author":"Gasche","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-2952(92)90286-R","article-title":"Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopy","volume":"43","author":"Allgayer","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02090074","article-title":"Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils","volume":"39","author":"Allgayer","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gut.44.2.180","article-title":"5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells","volume":"44","author":"McKenzie","year":"1999","journal-title":"Gut"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib49","first-page":"A-184","article-title":"Mesalamine downregulates oncogene c-myc and genes encoding transcription factors and signaling transduction molecules involved in cell survival and proliferation in colon cancer cells: molecular basis for chemopreventative action","volume":"130","author":"Chu","year":"2006","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib50","first-page":"A-693","article-title":"Dose-dependent inhibition of stem cell activation by 5-ASA: a possible explanation for the chemo preventative effect of %-ASA therapy in colitis-induced cancer","volume":"130","author":"Grimm","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0016-5085(89)90058-9","article-title":"Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study","volume":"97","author":"Lashner","year":"1989","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib54","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib55","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib57","first-page":"A-653","article-title":"Mesalamine reduces the rate of colorectal dysplasia in patients with inflammatory bowel disease and primary sclerosing cholangitis who are on ursodeoxycholic acid","volume":"130","author":"Smith","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0016-5085(94)90068-X","article-title":"Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study","volume":"107","author":"Pinczowski","year":"1994","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2006.07.003_bib59","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00042737-199612000-00009","article-title":"Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire","volume":"8","author":"Moody","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","article-title":"The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis","volume":"112","author":"Lashner","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.2000.00698.x","article-title":"Colorectal cancer prevention in ulcerative colitis: a case-control study","volume":"14","author":"Eaden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.18.s2.3.x","article-title":"Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease","volume":"18","author":"Eaden","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02234825","article-title":"Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study","volume":"44","author":"Lindberg","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.gtc.2006.07.003_bib64","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2003.08718.x","article-title":"Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?","volume":"98","author":"Bernstein","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4 Suppl 1","key":"10.1016\/j.gtc.2006.07.003_bib65","doi-asserted-by":"crossref","first-page":"A-36","DOI":"10.1016\/S0016-5085(03)80178-6","article-title":"Use of 5-ASA is associated with decreased risk of dysplasia and colon cancer (CRC) in ulcerative colitis (UC)","volume":"124","author":"Rubin","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gtc.2006.07.003_bib66","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/gut.2005.070896","article-title":"5-Aminosalicylate use and colorectal cancer risk in\u00a0inflammatory bowel disease: a large epidemiological study","volume":"54","author":"van Staa","year":"2005","journal-title":"Gut"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib67","first-page":"A-299","article-title":"A case-control of 5-aminosalicylic acid therapy in the prevention of colitis-related colorectal cancer","volume":"128","author":"Terdiman","year":"2005","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib68","first-page":"A-2","article-title":"Risk factors for colorectal cancer in Crohn's colitis: a case-control study","volume":"130","author":"Siegel","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib69","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib70","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.dld.2005.02.012","article-title":"5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?","volume":"37","author":"Giannini","year":"2005","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib71","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1572-0241.2005.50218.x","article-title":"Will a 5-ASA a day keep the cancer (and dysplasia) away?","volume":"100","author":"Rubin","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib72","first-page":"A-647","article-title":"Determinants of progression of indefinite or low-grade dysplasia to advance dysplasia in ulcerative colitis","volume":"130","author":"Akram","year":"2006","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib73","first-page":"A-2","article-title":"Colorectal cancer survival in ulcerative colitis is associated with prior use of\u00a05-aminosalicylic acid but not surveillance colonoscopy","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib74","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"Ullman","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-107-4-513","article-title":"Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease","volume":"107","author":"Kaufmann","year":"1987","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib76","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00054725-200411000-00009","article-title":"A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease","volume":"10","author":"Bonner","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","article-title":"Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease","volume":"4","author":"Takeuchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib81","first-page":"44","article-title":"Risk factors of colorectal cancer in inflammatory bowel disease","volume":"91","author":"Bansal","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.gtc.2006.07.003_bib82","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"issue":"8996","key":"10.1016\/j.gtc.2006.07.003_bib83","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","article-title":"Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine","volume":"347","author":"Bouhnik","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib84","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/rheumatology\/35.8.738","article-title":"Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib85","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1523-1755.2004.00741.x","article-title":"Risk of malignancy with long-term immunosuppression in renal transplant recipients","volume":"66","author":"Agraharkar","year":"2004","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib87","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"issue":"8908","key":"10.1016\/j.gtc.2006.07.003_bib88","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib89","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1046\/j.1365-2036.2002.01297.x","article-title":"Long-term risk of malignancy after treatment of\u00a0inflammatory bowel disease with azathioprine","volume":"16","author":"Fraser","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.gtc.2006.07.003_bib90","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1542-3565(05)00738-X","article-title":"Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine","volume":"3","author":"Matula","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gtc.2004.02.004","article-title":"Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine","volume":"33","author":"Su","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib92","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib93","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"8552","key":"10.1016\/j.gtc.2006.07.003_bib94","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(87)90766-5","article-title":"Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis","volume":"2","author":"Hill","year":"1987","journal-title":"Lancet"},{"issue":"7\u20138","key":"10.1016\/j.gtc.2006.07.003_bib95","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0959-8049(95)00216-6","article-title":"Role of bile acids in colorectal carcinogenesis","volume":"31A","author":"Nagengast","year":"1995","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/01635589809514689","article-title":"Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation","volume":"31","author":"Martinez","year":"1998","journal-title":"Nutr Cancer"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib97","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/bbrc.1999.1403","article-title":"Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants","volume":"263","author":"Mitsuyoshi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.gtc.2006.07.003_bib98","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-134-2-200101160-00017","article-title":"Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research","volume":"134","author":"Hawk","year":"2001","journal-title":"Ann Intern Med"},{"issue":"5B","key":"10.1016\/j.gtc.2006.07.003_bib99","first-page":"3121","article-title":"Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and\/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study","volume":"24","author":"Sjoqvist","year":"2004","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.gtc.2006.07.003_bib100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ajcn\/65.1.46","article-title":"Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene","volume":"65","author":"Kim","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"4696","key":"10.1016\/j.gtc.2006.07.003_bib102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1126\/science.2579435","article-title":"Hypomethylation of DNA from benign and malignant human colon neoplasms","volume":"228","author":"Goelz","year":"1985","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib103","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-129-7-199810010-00002","article-title":"Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study","volume":"129","author":"Giovannucci","year":"1998","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.gtc.2006.07.003_bib104","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/85.11.875","article-title":"Folate, methionine, and alcohol intake and risk of colorectal adenoma","volume":"85","author":"Giovannucci","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.gtc.2006.07.003_bib105","first-page":"1019","article-title":"Folate deficiency in chronic inflammatory bowel diseases","volume":"14","author":"Elsborg","year":"1979","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.22.6.456","article-title":"Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis","volume":"22","author":"Swinson","year":"1981","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0016-5085(73)80120-9","article-title":"Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine)","volume":"64","author":"Franklin","year":"1973","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib108","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1172\/JCI108921","article-title":"Inhibition of folate enzymes by sulfasalazine","volume":"61","author":"Selhub","year":"1978","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.gtc.2006.07.003_bib109","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF01686465","article-title":"Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis","volume":"119","author":"Lashner","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib110","first-page":"469","article-title":"Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis","volume":"6","author":"Biasco","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib111","first-page":"1156","article-title":"Rectal cell proliferation and colon cancer risk in\u00a0ulcerative colitis","volume":"50","author":"Biasco","year":"1990","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib112","first-page":"1323","article-title":"Colon cancer and dietary fat, phosphate, and calcium: a hypothesis","volume":"72","author":"Newmark","year":"1984","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"10.1016\/j.gtc.2006.07.003_bib113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3835(97)04629-6","article-title":"Mechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesis","volume":"114","author":"Van der Meer","year":"1997","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gtc.2006.07.003_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003548.pub3","article-title":"Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps","volume":"3","author":"Weingarten","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.gtc.2006.07.003_bib115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","article-title":"Calcium plus vitamin D supplementation and the risk of colorectal cancer","volume":"354","author":"Wactawski-Wende","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gtc.2006.07.003_bib116","first-page":"1021","article-title":"Calcium and colorectal epithelial cell proliferation in ulcerative colitis","volume":"6","author":"Bostick","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.gtc.2006.07.003_bib117","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib118","first-page":"A-62","article-title":"Statins reduce the risk of pancreatic cancer in humans: half a million US veterans' case control study","volume":"128","author":"Khurana","year":"2005","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1016\/j.gtc.2006.07.003_bib119","first-page":"A-93","article-title":"Statins reduce the incidence of esophageal cancer: a study of half a million US veterans","volume":"128","author":"Khurana","year":"2005","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.gtc.2006.07.003_bib120","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Poynter","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib121","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/1097-0142(19860901)58:5<1167::AID-CNCR2820580532>3.0.CO;2-R","article-title":"Colorectal adenomatous polyps and carcinoma in Ashkenazi and non-Ashkenazi Jews in Israel","volume":"58","author":"Bat","year":"1986","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gtc.2006.07.003_bib122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2407-5-46","article-title":"Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands","volume":"5","author":"Kohno","year":"2005","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib123","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1053\/gast.1996.v110.pm8964397","article-title":"Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model","volume":"110","author":"D'Argenio","year":"1996","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2006.07.003_bib124","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1349-7006.2001.tb01108.x","article-title":"Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats","volume":"92","author":"Kohno","year":"2001","journal-title":"Jpn J Cancer Res"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib125","first-page":"2424","article-title":"Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats","volume":"61","author":"Tanaka","year":"2001","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.gtc.2006.07.003_bib126","first-page":"981","article-title":"Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats","volume":"11","author":"Takeda","year":"2004","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.gtc.2006.07.003_bib127","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/carcin\/23.6.993","article-title":"Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine","volume":"23","author":"Seril","year":"2002","journal-title":"Carcinogenesis"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855306000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855306000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:46:58Z","timestamp":1587318418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855306000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889855306000379"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2006.07.003","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}